Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Corina Intrauterine Drug-Eluting System approved in China as a novel treatment for patients with moderate-to-severe intrauterine adhesions (IUA) 2024-08-23 18:45
FINGERPRINT STUDY OF 1000 SINGAPOREANS SHOWS HIGH SELF-MANAGEMENT AND RESILIENCE TRAITS: BRILLIANAIRE 2024-08-23 13:46
Antengene Announces 2024 Interim Financial Results, Highlights Progress in R&D and Commercialization 2024-08-23 12:32
Getinge to acquire Paragonix Technologies, a growth leader in the organ transplantation market 2024-08-23 05:00
Alzheimer's Association Commends United Kingdom's Approval of Leqembi, But Condemns Decision to Deny NHS Access 2024-08-23 00:31
Ascentage Pharma Announces 2024 Interim Results 2024-08-22 23:36
Bridge Biotherapeutics and HitGen Initiate Research Collaboration to Advance Novel Cancer Therapeutics Program 2024-08-22 21:30
Ubie Announces Social Impact Framework, Shows Estimated Patient Life Expectancy Impact of 27,000 Years and Approximately $1BN 2024-08-22 21:30
Clarity receives FDA Fast Track Designation for 64Cu-SAR-bisPSMA 2024-08-22 21:04
Stem Cell Therapy developers I Peace and iCamuno Biotherapeutics Start Natural Killer Cell Trial for Ovarian Cancer 2024-08-22 21:00
Ractigen Therapeutics Announces U.S. FDA Orphan Drug Designation (ODD) granted to RAG-18 for the treatment of Duchenne Muscular Dystrophy and Becker Muscular Dystrophy 2024-08-22 20:00
YolTech Therapeutics Administers First Patient Dose in IIT of YOLT-203, the World's First In Vivo Gene Editing Therapy for PH1 2024-08-22 18:00
Telix 2024 Half-Year Results: Strong Commercial Revenue and Profit Growth to Support Strategic Priorities 2024-08-22 17:04
Inaugural Process Innovation Asia Pacific to Drive Industry Transformation for South-East Asia's Chemicals and Pharmaceuticals 2024-08-22 15:30
Chen Institute and Science to Hold Innovative Conference in Shanghai Spotlighting Latest Developments in "Artificial Intelligence and Mental Health" 2024-08-22 13:00
China's First Approved KRAS G12C Inhibitor: Innovent Announces the Approval of Dupert® (Fulzerasib) by the National Medical Products Administration of China 2024-08-22 08:00
Everest Medicines Announces the Initiation of an Investigator-Initiated Clinical Trial (IIT) for Personalized mRNA Cancer Vaccine Program EVM16 2024-08-22 08:00
WuXi Biologics Reports Solid 2024 Interim Results 2024-08-21 23:46
Sisram Medical Announces First-Half 2024 Financial Results 2024-08-21 21:53
UTime Limited Announces Ambitious AI Health Strategy and Strategic Collaboration 2024-08-21 21:25
1 46 47 48 49 50 1596